MapLight Therapeutics Inc
NASDAQ:MPLT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MapLight Therapeutics Inc
NASDAQ:MPLT
|
US |
|
Roche Holding AG
OTC:RHHBF
|
CH |
|
Koninklijke Philips NV
NYSE:PHG
|
NL |
|
X
|
Xinhua Winshare Publishing and Media Co Ltd
SSE:601811
|
CN |
|
Bytes Technology Group PLC
OTC:BYITY
|
UK |
|
Maple Leaf Foods Inc
TSX:MFI
|
CA |
|
O
|
Ocean Bio-Chem Inc
F:OBC
|
US |
|
B
|
Beforepay Group Ltd
ASX:B4P
|
AU |
Wall St Price Targets
MPLT Price Targets Summary
MapLight Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for MPLT is 38.42 USD with a low forecast of 30.3 USD and a high forecast of 47.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MPLT's stock price target?
Price Target
38.42
USD
According to Wall Street analysts, the average 1-year price target for MPLT is 38.42 USD with a low forecast of 30.3 USD and a high forecast of 47.25 USD.